نتایج جستجو برای: carbidopa

تعداد نتایج: 777  

Journal: :Cancer research 2008
Oliver C Neels Klaas P Koopmans Pieter L Jager Laya Vercauteren Aren van Waarde Janine Doorduin Hetty Timmer-Bosscha Adrienne H Brouwers Elisabeth G E de Vries Rudi A J O Dierckx Ido P Kema Philip H Elsinga

[(11)C]-5-Hydroxytryptophan ([(11)C]HTP) and 6-[(18)F]fluoro-3,4-dihydroxy-l-phenylalanine ([(18)F]FDOPA) are used to image neuroendocrine tumors with positron emission tomography. The precise mechanism by which these tracers accumulate in tumor cells is unknown. We aimed to study tracer uptake via large amino acid transporters, peripheral decarboxylation (inhibited by carbidopa), and intracell...

2009
Kapil D Sethi Robert A Hauser Stuart H Isaacson Terry McClain

Levodopa continues to be the most efficacious and widely used treatment for Parkinson's disease. Levodopa dosing is understood to be critical for the optimal control of symptoms, and increasing the levodopa dose is a common method to treat advancing disease. Escalating levodopa dosages coupled with disease progression is associated with increasing likelihood of developing levodopa-induced dyski...

Journal: :Chest 1992
P L Schiffman L I Golbe

We report the findings in a patient known to have olivopontocerebellar atrophy who developed respiratory distress, inspiratory stridor, and maximum inspiratory and expiratory flow volume loops. Treatment with carbidopa-levodopa gave symptomatic relief.

2017
Nirosen Vijiaratnam Shuli Cheng Kelly Lucinda Bertram David Richard Williams

2012
Stephen Wørlich Pedersen Jesper Clausen Mie Manon Gregerslund

Continuous dopaminergic delivery is recognized for the capacity to ameliorate symptoms in Parkinson's disease (PD). In advanced PD the short comings of orally administered Levodopa/Carbidopa include fluctuations resulting in unstable effect and dyskinesia. Levodopa/Carbidopa intestinal gel, LCIG, (Duodopa®, Abbott Laboratories) is delivered continuously through a percutaneous endoscopic gastros...

Journal: :Archives of neurology 2008
Edward G Neilan Mauricio R Delgado Melissa A Donovan Sara Y Kim Rita L Jou Bai-Lin Wu Peter B Kang

BACKGROUND Gait difficulties, tremors, and coordination difficulties are common features of Cockayne syndrome that are consequences of leukodystrophy, cerebellar atrophy, and demyelinating neuropathy, but no pharmacotherapy for these disabling symptoms is available. OBJECTIVE To determine whether carbidopa-levodopa relieves tremors and other motor complications of Cockayne syndrome. DESIGN ...

Journal: :Neurologia 2013
J Kulisevsky M R Luquin J M Arbelo J A Burguera F Carrillo A Castro J Chacón P J García-Ruiz E Lezcano P Mir J C Martinez-Castrillo I Martínez-Torres V Puente A Sesar F Valldeoriola-Serra R Yañez

INTRODUCTION Many patients who have had Parkinson's disease (PD) for several years will present severe motor fluctuations and dyskinesias which require more aggressive therapies. The different approaches which are now available include deep brain stimulation of the subthalamic nucleus or medial globus pallidus, subcutaneous infusion of apomorphine, and intestinal infusion of levodopa-carbidopa....

Journal: :British journal of clinical pharmacology 1994
T C Li Kam Wa S Freestone R R Samson N R Johnston M R Lee

1. The effects of inhibition of peripheral aromatic L-amino acid decarboxylase during infusion of the relatively renally selective 5-hydroxytryptamine (5-HT) prodrug, gamma-L-glutamyl-5-hydroxy-L-tryptophan (glu-5-HTP), were examined in eight healthy male subjects in a randomised, placebo-controlled, cross-over study. 2. Each subject received oral carbidopa (100 mg) or placebo followed, 1 h lat...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید